To investigate the effects of D-penicillamine (D-Pen) on angiogenesis, we have studied the effects of this drug on in vitro proliferation of human endothelial cells (EC) and in vivo corneal neovascularization. D-Pen, in the presence of copper sulfate, suppressed tritiated thymidine ([3H]TdR) incorporation into EC in a dose-dependent manner. Significant inhibition was observed with D-Pen concentrations attainable in the serum and tissues of treated patients. Neither D-Pen nor copper ion alone significantly affected [3H]TdR incorporation into EC. The inhibition by D-Pen and copper was blocked by catalase (CAT) or horseradish peroxidase but not by boiled CAT or SOD. When rabbits were daily injected intravenously with D-Pen at the per kilogram dosage administered to rheumatoid patients, neovascularization as quantitated by the proliferation of corneal new blood vessels was significantly inhibited. These results suggest that hydrogen peroxide generated by D-Pen and copper exerts a pronounced antiangiogenic effect through inhibition of EC proliferation. It is, therefore, considered that D-Pen may suppress rheumatoid synovitis by reducing the number of small blood vessels available for the emigration of chronic inflammatory cells, and the proliferation of the synovial tissue.
T Matsubara, R Saura, K Hirohata, M Ziff
Title and authors | Publication | Year |
---|---|---|
Using Small Molecules for Targeting Heavy Metals in Neurotoxicity and Neuroinflammation.
Biswas P, More SS |
Methods in molecular biology (Clifton, N.J.) | 2024 |
Copper in Gynecological Diseases.
Conforti RA, Delsouc MB, Zorychta E, Telleria CM, Casais M |
International journal of molecular sciences | 2023 |
The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy
P Lelièvre, L Sancey, JL Coll, A Deniaud, B Busser |
Cancers | 2020 |
The combination of disulfiram and copper for cancer treatment
H Li, J Wang, C Wu, L Wang, ZS Chen, W Cui |
Drug Discovery Today | 2020 |
Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy
K Gaur, A Vázquez-Salgado, G Duran-Camacho, I Dominguez-Martinez, J Benjamín-Rivera, L Fernández-Vega, LC Sarabia, AC García, F Pérez-Deliz, JM Román, M Vega-Cartagena, S Loza-Rosas, XR Acevedo, A Tinoco |
2018 | |
D-penicillamine and other low molecular weight thiols: Review of anticancer effects and related mechanisms
S Wadhwa, RJ Mumper |
Cancer Letters | 2013 |
D-Penicillamine for preventing retinopathy of prematurity in preterm infants
MJ Qureshi, M Kumar |
Cochrane Database of Systematic Reviews | 2013 |
Angiogenesis
TH Adair, JP Montani |
Colloquium Series on Integrated Systems Physiology: From Molecule to Function | 2010 |
Bioinorganic aspects of angiogenesis
LD D'Andrea, A Romanelli, RD Stasi, C Pedone |
Dalton Transactions | 2010 |
Turning tumor-promoting copper into an anti-cancer weapon via high-throughput chemistry
F Wang, P Jiao, M Qi, M Frezza, QP Dou, B Yan |
Current medicinal chemistry | 2010 |
Intracellular Delivery of the Reactive Oxygen Species Generating Agent d -Penicillamine upon Conjugation to Poly- l -glutamic Acid
S Wadhwa, RJ Mumper |
Molecular Pharmaceutics | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
A Gupte, RJ Mumper |
Cancer Treatment Reviews | 2009 |
An investigation into copper catalyzed D-penicillamine oxidation and subsequent hydrogen peroxide generation
A Gupte, RJ Mumper |
Journal of Inorganic Biochemistry | 2007 |
D-Penicillamine administration and the incidence of retinopathy of prematurity
RD Christensen, SC Alder, SC Richards, DK Lambert, N Schmutz, SE Wiedmeier, J Burnett, VL Baer, JT Horn, M Richards, J Barraza |
Journal of Perinatology | 2007 |
Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells
A Gupte, RJ Mumper |
Free radical biology & medicine | 2007 |
Side Effects of Drugs Annual
T Vial, J Descotes, F Braun, M Behrend |
Side Effects of Drugs Annual | 2007 |
Effects of combination of melatonin and dexamethasone on acute lung injury in a mice model of carrageenan-induced pleurisy
C Crisafulli, E Mazzon, C Muia, PD Bella, E Esposito, R Meli, S Cuzzocrea |
Journal of Pineal Research | 2006 |
Angiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators
RR de Groot-Besseling, TJ Ruers, IL Lamers-Elemans, CN Maass, RM de Waal, JR Westphal |
BMC Cancer | 2006 |
A pilot trial testing the feasibility of administering D-penicillamine to extremely low birth weight neonates
RD Christensen, SC Alder, SC Richards, JT Horn, DK Lambert, VL Baer |
Journal of Perinatology | 2006 |
The Cell Cycle in the Central Nervous System
D Janigro |
2006 | |
The Role of Copper in Tumour Angiogenesis
SA Lowndes, AL Harris |
Journal of Mammary Gland Biology and Neoplasia | 2005 |
Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis
S Cuzzocrea, E Mazzon, RD Paola, T Genovese, C Muià, AP Caputi, D Salvemini |
Arthritis & Rheumatism | 2005 |
Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction
Y Chen, E Donnelly, H Kobayashi, LM DeBusk, PC Lin |
Arthritis & Rheumatism | 2005 |
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma
S Brem, SA Grossman, KA Carson, P New, S Phuphanich, JB Alavi, T Mikkelsen, JD Fisher |
Neuro-Oncology | 2005 |
A Requirement for Copper in Angiogenesis
ED Harris |
Nutrition Reviews | 2004 |
Angiogenesis in Glioma
O Bögler, T Mikkelsen |
The Cancer Journal | 2003 |
Molekularmedizinische Grundlagen von rheumatischen Erkrankungen
D Ganten, K Ruckpaul, S Gay, JR Kalden |
2003 | |
Physiological electric fields control the G 1 /S phase cell cycle checkpoint to inhibit endothelial cell proliferation
E Wang, Y Yin, M Zhao, JV Forrester, CD McCaig |
The FASEB Journal | 2003 |
Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis
A Coxon, B Bolon, J Estrada, S Kaufman, S Scully, A Rattan, D Duryea, YL Hu, K Rex, E Pacheco, G Van, D Zack, U Feige |
Arthritis & Rheumatism | 2002 |
Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective
JP Case |
American Journal of Therapeutics | 2001 |
Angiogenesis in the pathogenesis of inflammatory joint and lung diseases
DA Walsh, CI Pearson |
Arthritis research | 2001 |
Head and Neck Cancer
A Forastiere, W Koch, A Trotti, D Sidransky |
New England Journal of Medicine | 2001 |
Copper Induces the Assembly of a Multiprotein Aggregate Implicated in the Release of Fibroblast Growth Factor 1 in Response to Stress
M Landriscina, C Bagalá, A Mandinova, R Soldi, I Micucci, S Bellum, I Prudovsky, T Maciag |
The Journal of biological chemistry | 2001 |
Angiogenèse : mécanismes généraux et implications au cours de la polyarthrite rhumatoïde
AJ Weber, MD Bandt |
Revue du Rhumatisme | 2000 |
Handbook of Oxidants and Antioxidants in Exercise
RR Jenkins, J Beard |
Handbook of Oxidants and Antioxidants in Exercise | 2000 |
Effects of combinations of anti‐rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis
M Nagashima, K Wauke, D Hirano, S Ishigami, H Aono, M Takai, M Sasano, S Yoshino |
Rheumatology (Oxford, England) | 2000 |
Blood Perfusion and Microenvironment of Human Tumors
M Molls, P Vaupel |
2000 | |
Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo
OV Volpert, WF Ward, MW Lingen, L Chesler, DB Solt, MD Johnson, A Molteni, PJ Polverini, NP Bouck |
Journal of Clinical Investigation | 1999 |
Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells
M Nagashima, S Yoshino, H Aono, M Takai, M Sasano |
Clinical & Experimental Immunology | 1999 |
Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo
OV Volpert, WF Ward, MW Lingen, L Chesler, DB Solt, MD Johnson, A Molteni, PJ Polverini, NP Bouck |
Journal of Clinical Investigation | 1999 |
A role for angiogenesis in rheumatoid arthritis
DG Stupack, CM Storgard, DA Cheresh |
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.] | 1999 |
Angiogenesis and Cancer Control: From Concept to Therapeutic Trial
S Brem |
Cancer control : journal of the Moffitt Cancer Center | 1999 |
Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitor
J Horti, SC Dixon, CJ Logothetis, Y Guo, E Reed, WD Figg |
British Journal of Cancer | 1999 |
Angiogenesis: Implications for rheumatoid arthritis
AE Koch |
Arthritis & Rheumatism | 1998 |
Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging
K Gaffney, J Cookson, S Blades, A Coumbe, D Blake |
Annals of the rheumatic diseases | 1998 |
Neomycin inhibits angiogenin-induced angiogenesis
GF Hu |
Proceedings of the National Academy of Sciences | 1998 |
Transgenic mice model of ocular neovascularization driven by vascular endothelial growth factor (VEGF) overexpression
L Lakatos |
The American Journal of Pathology | 1998 |
Gene Therapy Strategies for Tumor Antiangiogenesis
HL Kong, RG Crystal |
JNCI Journal of the National Cancer Institute | 1998 |
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
S Gately, P Twardowski, MS Stack, DL Cundiff, D Grella, FJ Castellino, J Enghild, HC Kwaan, F Lee, RA Kramer, O Volpert, N Bouck, GA Soff |
Proceedings of the National Academy of Sciences | 1997 |
The Kinin System
A Schmaier |
The Kinin System | 1997 |
Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell
AK Singh, GS Sidhu, T Deepa, RK Maheshwari |
Cancer Letters | 1996 |
Effects of antirheumatic agents on cytokines
P Barrera, AM Boerbooms, LB van de Putte, JW van der Meer |
Seminars in Arthritis and Rheumatism | 1996 |
Bufalin inhibits endothelial cell proliferation and angiogenesis in vitro
DY Lee, M Yasuda, T Yamamoto, T Yoshida, Y Kuroiwa |
Life Sciences | 1996 |
Molecular biology of dissemination in bladder cancer ? laboratory findings and clinical significance
BJ Schmitz-Drger, F Jankevicius, R Ackermann |
World Journal of Urology | 1996 |
Copper Chelation Inhibits Tumor Angiogenesis in the Experimental 9L Gliosarcoma Model
D Yoshida, Y Ikeda, S Nakazawa |
Neurosurgery | 1995 |
Endothelial cells in culture: a model to study in vitro vascular toxicity
O Chappey, MP Wautier, JL Wautier |
Toxicology in Vitro | 1995 |
The effect of auranofin and sulphasalazine therapy on circulating levels of interleukin 6 in rheumatoid arthritis patients
A Crilly, HA Capell, J Watson, R Madhok |
Clinical Rheumatology | 1995 |
Tumour vasculature--a potential therapeutic target
CT Baillie, MC Winslet, NJ Bradley |
British Journal of Cancer | 1995 |
A novel angiogenesis inhibitor suppresses rat adjuvant arthritis
DJ Peacock, ML Banquerigo, E Brahn |
Cellular Immunology | 1995 |
Advances in Drug Research
CL Crespi |
Advances in Drug Research | 1995 |
Copper Chelation Inhibits Tumor Angiogenesis in the Experimental 9L Gliosarcoma Model:
D Yoshida, Y Ikeda, S Nakazawa |
Neurosurgery | 1995 |
Antiangiogenesis as a novel therapeutic concept in pediatric oncology
L Schweigerer |
Journal of Molecular Medicine | 1995 |
Inhibition of neovascularization in vivo by gold compounds
R Saura, T Matsubara, K Mizuno |
Rheumatology International | 1994 |
Inhibition of Tumor Angiogenesis
EP Sipos, RJ Tamargo, JD Weingart, H Brem |
Annals of the New York Academy of Sciences | 1994 |
Angiogenesis inhibition: A review
W Auerbach, R Auerbach |
Pharmacology & Therapeutics | 1994 |
Inhibition of inflammatory angiogenesis in rats by loco-regional administration of hydrocortisone and protamine
D Foschi, L Castoldi, F Corsi, E Radaelli, E Trabucchi |
Agents and Actions | 1994 |
Does improved control of tumour growth require an anti-cancer therapy targeting both neoplastic and intratumoral endothelial cells?
G Gasparini, AL Harris |
European Journal of Cancer | 1994 |
Assay of the antiangiogenic compound TNP-470, and one of its metabolites, AGM-1883, by reversed-phase high-performance liquid chromatography in plasma
WD Figg, HJ Yeh, A Thibault, JM Pluda, F Itoh, R Yarchoan, MR Cooper |
Journal of Chromatography B Biomedical Sciences and Applications | 1994 |
Inhibition of mitogen-induced response of human peripheral blood mononuclear cells by bucillamine, a new antirheumatic sulfhydryl drug
T Akamatsu, T Matsubara, Y Saegusa, K Mizuno |
Rheumatology International | 1994 |
Endothelial proliferation in experimental granulomatous colitis: Autoradiography and immunohistochemistry studies
N Pooley, L Ghosh, J Blanchard, P Sharon |
Digestive Diseases and Sciences | 1994 |
Suppression of 9L gliosarcoma growth by copper depletion with copper-deficient diet and D-Penicillamine
D Yoshida, Y Ikeda, S Nakazawa |
Journal of Neuro-Oncology | 1993 |
Anti-angiogenesis: a multipurpose therapeutic tool?
D Ribatti, A Vacca, M Bertossi, L Roncali |
International Journal of Clinical & Laboratory Research | 1993 |
Cutaneous malignant melanoma
SJ Hoffman, JJ Yohn, DA Norris, CM Smith, WA Robinson |
Current Problems in Dermatology | 1993 |
Formation of DNA strand breaks by D-penicillamine and bucillamine in human lymphocytes
H Yamanaka, M Hakoda, N Kamatani, S Kashiwazaki, DA Carson |
Immunopharmacology | 1993 |
Humoral Factors in the Regulation of Tissue Growth
PP Foà |
1993 | |
Oncogenes and Tumor Suppressor Genes in Human Malignancies
CC Benz, ET Liu |
1993 | |
Ionic regulation of human basophil releasability. I. Inhibitory effect of copper
A Tedeschi, M Arquati, M Lorini, N Milazzo, A Miadonna |
Agents and Actions | 1992 |
Angiogenesis and angiogenesis inhibitors in paediatric diseases
L Schweigerer, T Fotsis |
European Journal of Pediatrics | 1992 |
Angiogenesis inhibition suppresses collagen arthritis
DJ Peacock, ML Banquerigo, E Brahn |
Journal of Experimental Medicine | 1992 |
Short-term dietary copper deficiency does not inhibit angiogenesis in tumours implanted in striated muscle
DA Schuschke, MW Reed, JT Saari, MD Olson, DM Ackermann, FN Miller |
British Journal of Cancer | 1992 |
Effects of nicardipine on tube formation of bovine vascular endothelial cells in vitro
T Kaneko, I Nagata, S Miyamoto, H Kubo, H Kikuchi, T Fujisato, Y Ikada |
Stroke; a journal of cerebral circulation | 1992 |
Emoxypine as an inhibitor of angiogenesis
AA Sologub, SI Akberova, GG Ziangirova |
Bulletin of Experimental Biology and Medicine | 1992 |
Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications
PR Colville-Nash, DL Scott |
Annals of the rheumatic diseases | 1992 |
Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis
AJ Farrell, RB Williams, CR Stevens, AS Lawrie, NL Cox, DR Blake |
Annals of the rheumatic diseases | 1992 |
Eicosapentaenoic acid inhibits tube formation of vascular endothelial cellsin vitro
T Kanayasu, I Morita, J Nakao-Hayashi, N Asuwa, C Fujisawa, T Ishii, H Ito, S Murota |
Lipids | 1991 |
Effects of lobenzarit disodium on human endothelial cells. Lobenzarit disodium inhibits proliferative response, HLA–DR antigen expression, and T cell adherence toward endothelial cells
A Kawakami, K Eguchi, Y Ueki, K Migita, H Ida, H Nakao, A Kurata, T Fukuda, S Nagataki, T Ishimaru, K Kurouji, N Fujita |
Arthritis & Rheumatism | 1991 |
Novel growth regulatory factors and tumour angiogenesis
R Bicknell, AL Harris |
European Journal of Cancer and Clinical Oncology | 1991 |
Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor
SS Brem, D Zagzag, AM Tsanaclis, S Gately, MP Elkouby, SE Brien |
The American Journal of Pathology | 1990 |
How to Characterize a Biological Antioxidant
B Halliwell |
Free Radical Research | 1990 |
Development of angiogenesis inhibitors for clinical applications
TE Maione, RJ Sharpe |
Trends in Pharmacological Sciences | 1990 |
d-Penicillamine
DA Joyce |
Baillière's Clinical Rheumatology | 1990 |
The heat shock protein response and its role in inflammatory disease
VR Winrow, L McLean, CJ Morris, DR Blake |
Annals of the rheumatic diseases | 1990 |
CuSO4 as an Inhibitor of B Cell Proliferation
T YAMAUCHI, I YAMAMOTO |
The Japanese Journal of Pharmacology | 1990 |
Correspondence
I Chanarin, L Szur |
British Journal of Haematology | 1975 |